Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Centrum voor Kankeropsporing from Brugge, company number BE0870354868, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year Centrum voor Kankeropsporing recorded a gross margin of € -350,180 and equity of € 436,539. Compared with financial year 2024, the result moved from € -760,041 to € -1.2 million. The company made a loss. The buffer shrank hard: equity is 74 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 23, 2026.
€ 436,539
▼ 74% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.2 million
▼ 64 % more loss than in 2024
Profit after tax over the fiscal year.
€ 2.1 million
▲ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
7.3
▲ 1.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 586,750
▲ 22% vs 2024
€ 80,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 10,263
▲ € 7,857 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 441,049
▼ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 116,520
▲ 44% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 650,674 | € 483,950 | € -290,758 | € -350,180 | ▼ € 59,422 |
| Profit after taxes | € 256,949 | € 33,460 | € -760,041 | € -1,247,156 | ▼ € 487,115 |
| Equity | € 2,410,276 | € 2,443,736 | € 1,683,695 | € 436,539 | ▼ 74% |
| Total debts | € 1,154,481 | € 1,839,480 | € 1,748,986 | € 1,726,377 | ▼ 1% |
| Cash | € 2,807,084 | € 3,382,623 | € 1,614,397 | € 2,111,232 | ▲ 31% |
| Retained profit | € 2,410,276 | € 2,443,736 | € 1,683,695 | € 436,539 | ▼ 74% |
| Balance sheet total | € 3,564,757 | € 4,283,216 | € 3,432,681 | € 2,162,916 | ▼ 37% |
| Employees (FTE) | 4.7 | 5.4 | 5.9 | 7.3 | ▲ 1.4 |
Key figures of Centrum voor Kankeropsporing, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Centrum voor Kankeropsporing the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Centrum voor Kankeropsporing?
What happened at Centrum voor Kankeropsporing in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dirk Corens stepped down as director. NBB
- Hilde Bosmans stepped down as director. NBB
- Bart Garmyn stepped down as director. NBB
- Harlinde De Schutter stepped down as director. NBB
- Erik Van Limbergen stepped down as director. NBB
- Herwig Deconinck stepped down as director. NBB
- An Vijverman stepped down as director. NBB
- Delphine De Smedt stepped down as director. NBB
In short
From € 256,949 profit in 2022 to € 1.2 million loss in 2025.
Paid € 15,306 in corporate taxes since 2022.
Best year ever: 2022, with € 256,949 profit.
On average € 89,600 of value added per employee in 2023.
Management
Directors
According to the 2025 annual accounts
Dirk Corens
Director
since 2024 · until 2028
Hilde Bosmans
Director
since 2024 · until 2028
Bart Garmyn
Director
since 2024 · until 2028
Harlinde De Schutter
Director
since 2024 · until 2028
Erik Van Limbergen
Chairman of the board
since 2024 · until 2028
since 2024 · until 2028
An Vijverman
Director
since 2024 · until 2028
Delphine De Smedt
Director
since 2024 · until 2028
Koen Van Herck
Director
since 2024 · until 2028
Establishments
Establishment units
Physical locations of this company
Ruddershove 4
8000 Brugge
Universiteitsplein 1
2610 Antwerpen
Active since 8 July 2019
Kapucijnenvoer 7
3000 Leuven
Active since 1 January 2015
Corneel Heymanslaan 10
9000 Gent
Active since 2 January 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →Openbaar Centrum voor Maatschappelijke Welzijn van Brugge
VERENIGING WOK
Vroegtijdige Opsporing Brugge
€ 456,265 gross margin · 2025
Mintus
Btw-eenheid Openbare Zorg en Welzijn Brugge
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0870.354.868
- VAT number
- BE 0870.354.868
- Registered office
- Ruddershove 4, 8000 Brugge
- Names & denominations
- Centrum voor Kankeropsporing · CvKO
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 3 December 2004
- Peppol
- Active · Active since 21 Oct 2026
- Contact
- bevolkingsonderzoek.be
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering
Gegevensverwerking, webhosting en aanverwante activiteiten
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten